AS

Anil Singh

Active Director Director DIN 10247294
DIN 10247294 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Anil Singh

Data last updated:

Anil Singh is a Director at George & Gem's Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. George & Gem's Pharmaceuticals Private Limited reported revenue of ₹1.71 Cr (FY 2025).

DIN 10247294
Primary Designation Director
Industry Pharma
First Appointment 22 Jul 2023
Oldest Company Age 15 yrs
Largest company George & Gem's Pharmaceuticals Private Limited · ₹1.71 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jul 20232011₹1.71 Cr (FY 2025)Active

Board colleagues of Anil Singh

Directorship timeline

Open interactive timeline →
George & Gem's Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anil Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Singh

Anil Singh currently holds 1 directorship: George & Gem's Pharmaceuticals Private Limited (Director, since 22 Jul 2023, revenue ₹1.71 Cr (FY 2025)).

Anil Singh was first appointed on 22 Jul 2023 as Director at George & Gem's Pharmaceuticals Private Limited.

The current boards of Anil Singh's companies include Janmejay Singh (George & Gem's Pharmaceuticals Private Limited), Vinay Pratap Singh (George & Gem's Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available